EPZ-6438 (Tazemetostat) VS GSK126 | 3-Deazaneplanocin A (DZNep) Hydrochloride

Jump to:

• EPZ-6438 (Tazemetostat) Mechanism of Action: EZH2 Inhibition in B-Cell Research
• EPZ-6438 (Tazemetostat) Working Concentration | Cell Culture | Treatment
• EPZ-6438 (Tazemetostat) Solubility in DMSO
• EPZ-6438 (Tazemetostat) Storage & Stability
• EPZ-6438 (Tazemetostat) Molecular Weight | Chemical Structure | Stock Solution
• EPZ-6438 (Tazemetostat) IC50 for Cell-based and Cell-free Assays
• EPZ-6438 (Tazemetostat) Sigma (SBR00098)? Try a better option.
• EPZ-6438 (Tazemetostat) MCE (HY-13803)? Try a better option.
• EPZ-6438 (Tazemetostat) Cayman (16174)? Try a better option.
• EPZ-6438 (Tazemetostat) Tocris (8093)? Try a better option.
• EPZ-6438 (Tazemetostat) TargetMol (T1788)? Try a better option.
• EPZ-6438 (Tazemetostat) SDS｜MSDS
• EPZ-6438 (Tazemetostat) in Follicular Lymphoma
• EPZ-6438 (Tazemetostat) in Epithelioid Sarcoma
• EPZ-6438 (Tazemetostat) in Solid Tumors